Clinical Study Demonstrates Improved Musculoskeletal Structure for Stronger, More Resilient Joints

Kinexa is a patented combination of standardized extracts of Haritaki (Terminalia chebula), Turmeric (Curcuma longa), and Indian Frankincense (Boswellia serrata).

The clinical study on Kinexa is currently not published, but we'd like to provide you with more information on the trial. Please fill out the form on this page and we will contact you.

Study Highlights

A Breakthrough Study Joint Longevity

In the recent clinical study, 100 subjects aged 40–75 with Grade II or III osteoarthritis received 200 mg/day of Kinexa or a matching placebo for six months. Assessments occurred at baseline, 1, 2, 4, and 6 months. Key outcomes included WOMAC, VAS, and Lequesne Functional Index (LFI) scores. Functional measures included isometric knee torque, a 6-minute walk test, and a Timed Get Up and Go test. The study incorporated advanced MRI imaging techniques rarely utilized in dietary supplement research, including quantitative and semi-quantitative measures of cartilage and whole-joint structural integrity, which includes ligaments, menisci, subchondral bone, and synovium. Biomarkers of inflammation and cartilage metabolism were also evaluated.